(2S)-3-[[2-[[3-[3-(adamantane-1-carbonylamino)propanoylamino]-5-guanidinobenzoyl]amino]acetyl]amino]-2-[[(2S)-1-(benzenesulfonyl)pyrrolidine-2-carbonyl]amino]propanoic acid

ID: ALA4749110

Chembl Id: CHEMBL4749110

PubChem CID: 162649513

Max Phase: Preclinical

Molecular Formula: C38H49N9O9S

Molecular Weight: 807.93

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)Nc1cc(NC(=O)CCNC(=O)C23CC4CC(CC(C4)C2)C3)cc(C(=O)NCC(=O)NC[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)c1

Standard InChI:  InChI=1S/C38H49N9O9S/c39-37(40)45-27-15-25(14-26(16-27)44-31(48)8-9-41-36(54)38-17-22-11-23(18-38)13-24(12-22)19-38)33(50)43-21-32(49)42-20-29(35(52)53)46-34(51)30-7-4-10-47(30)57(55,56)28-5-2-1-3-6-28/h1-3,5-6,14-16,22-24,29-30H,4,7-13,17-21H2,(H,41,54)(H,42,49)(H,43,50)(H,44,48)(H,46,51)(H,52,53)(H4,39,40,45)/t22?,23?,24?,29-,30-,38?/m0/s1

Standard InChI Key:  SAFQBUKUEAMDGO-GAQHEQIDSA-N

Alternative Forms

  1. Parent:

    ALA4749110

    ---

Associated Targets(Human)

ITGB1 Tclin Integrin alpha-5/beta-1 (686 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-V/beta-1 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-5 (589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-6 (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAV Tchem Integrin alpha-V/beta-8 (181 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB1 Tclin Integrin alpha-4/beta-1 (2269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 807.93Molecular Weight (Monoisotopic): 807.3374AlogP: 0.92#Rotatable Bonds: 16
Polar Surface Area: 282.08Molecular Species: ZWITTERIONHBA: 9HBD: 9
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.03CX Basic pKa: 9.03CX LogP: -1.70CX LogD: -1.71
Aromatic Rings: 2Heavy Atoms: 57QED Weighted: 0.08Np Likeness Score: -1.23

References

1. Sundaram A,Chen C,Isik Reed N,Liu S,Ki Yeon S,McIntosh J,Tang YZ,Yang H,Adler M,Beresis R,Seiple IB,Sheppard D,DeGrado WF,Jo H.  (2020)  Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness.,  30  (22): [PMID:33007395] [10.1016/j.bmcl.2020.127578]

Source